These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 36194543)

  • 21. Transposable Element Insertions into the Escherichia coli Polysialic Acid Gene Cluster Result in Resistance to the K1F Bacteriophage.
    Styles KM; Locke RK; Cowley LA; Brown AT; Sagona AP
    Microbiol Spectr; 2022 Jun; 10(3):e0211221. PubMed ID: 35467398
    [TBL] [Abstract][Full Text] [Related]  

  • 22.
    Laird T; Abraham R; Sahibzada S; Abraham S; O'Dea M
    Appl Environ Microbiol; 2022 Apr; 88(7):e0227621. PubMed ID: 35254097
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cell-Free Synthesis and Quantitation of Bacteriophages.
    Levrier A; Bowden S; Nash B; Lindner A; Noireaux V
    Methods Mol Biol; 2024; 2760():447-461. PubMed ID: 38468103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phage engineering and phage-assisted CRISPR-Cas delivery to combat multidrug-resistant pathogens.
    Khambhati K; Bhattacharjee G; Gohil N; Dhanoa GK; Sagona AP; Mani I; Bui NL; Chu DT; Karapurkar JK; Jang SH; Chung HY; Maurya R; Alzahrani KJ; Ramakrishna S; Singh V
    Bioeng Transl Med; 2023 Mar; 8(2):e10381. PubMed ID: 36925687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetic Engineering and Biosynthesis Technology: Keys to Unlocking the Chains of Phage Therapy.
    Lv S; Wang Y; Jiang K; Guo X; Zhang J; Zhou F; Li Q; Jiang Y; Yang C; Teng T
    Viruses; 2023 Aug; 15(8):. PubMed ID: 37632078
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Šimoliūnienė M; Kazlauskas D; Zajančkauskaitė A; Meškys R; Truncaitė L
    Biochim Biophys Acta Gen Subj; 2021 Oct; 1865(10):129967. PubMed ID: 34324954
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver sinusoidal cells eliminate blood-borne phage K1F.
    Sánchez Romano J; Simón-Santamaría J; McCourt P; Smedsrød B; Mortensen KE; Sagona AP; Sørensen KK; Larsen AK
    mSphere; 2024 Mar; 9(3):e0070223. PubMed ID: 38415633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and characterization of two bacteriophages with lytic activity against multidrug-resistant Escherichia coli.
    Fu P; Zhao Q; Shi L; Xiong Q; Ren Z; Xu H; Chai S; Xu Q; Sun X; Sang M
    Virus Res; 2021 Jan; 291():198196. PubMed ID: 33098914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic engineering of bacteriophages: Key concepts, strategies, and applications.
    Hussain W; Yang X; Ullah M; Wang H; Aziz A; Xu F; Asif M; Ullah MW; Wang S
    Biotechnol Adv; 2023; 64():108116. PubMed ID: 36773707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional Analysis of Bacteriophage Immunity through a Type I-E CRISPR-Cas System in Vibrio cholerae and Its Application in Bacteriophage Genome Engineering.
    Box AM; McGuffie MJ; O'Hara BJ; Seed KD
    J Bacteriol; 2016 Feb; 198(3):578-90. PubMed ID: 26598368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancing phage therapy through synthetic biology and genome engineering.
    Lenneman BR; Fernbach J; Loessner MJ; Lu TK; Kilcher S
    Curr Opin Biotechnol; 2021 Apr; 68():151-159. PubMed ID: 33310655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Applications of designer phage encoding recombinant gene payloads.
    Schmitt DS; Siegel SD; Selle K
    Trends Biotechnol; 2024 Mar; 42(3):326-338. PubMed ID: 37833198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genomic characterization of three bacteriophages targeting multidrug resistant clinical isolates of Escherichia, Klebsiella and Salmonella.
    Nepal R; Houtak G; Karki S; Dhungana G; Vreugde S; Malla R
    Arch Microbiol; 2022 May; 204(6):334. PubMed ID: 35585249
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Engineered Reporter Phages for Rapid Bioluminescence-Based Detection and Differentiation of Viable
    Meile S; Sarbach A; Du J; Schuppler M; Saez C; Loessner MJ; Kilcher S
    Appl Environ Microbiol; 2020 May; 86(11):. PubMed ID: 32245761
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing Methods to Genetically Engineer Bacteriophage and Increase Host Range.
    Kovacs CJ; Antonacci A; Graham A; Jessup F; Rankin W; Brasko B; Maguire F; Washington MA; Kua SC; Burpo FJ; Barnhill JC
    Mil Med; 2024 Jul; 189(7-8):e1488-e1496. PubMed ID: 38780999
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reporter Phage-Based Detection of Bacterial Pathogens: Design Guidelines and Recent Developments.
    Meile S; Kilcher S; Loessner MJ; Dunne M
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32858938
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular Basis for Lytic Bacteriophage Resistance in Enterococci.
    Duerkop BA; Huo W; Bhardwaj P; Palmer KL; Hooper LV
    mBio; 2016 Aug; 7(4):. PubMed ID: 27578757
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Engineered Bacteriophage Therapeutics: Rationale, Challenges and Future.
    Łobocka M; Dąbrowska K; Górski A
    BioDrugs; 2021 May; 35(3):255-280. PubMed ID: 33881767
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Viruses versus bacteria-novel approaches to phage therapy as a tool against multidrug-resistant pathogens.
    Viertel TM; Ritter K; Horz HP
    J Antimicrob Chemother; 2014 Sep; 69(9):2326-36. PubMed ID: 24872344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Isolation and Characterization of Novel Phages Targeting Pathogenic
    Li N; Zeng Y; Bao R; Zhu T; Tan D; Hu B
    Front Cell Infect Microbiol; 2021; 11():792305. PubMed ID: 34926329
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.